These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 9439876

  • 1. An overview and ranking of biochemical markers of cardiac disease. Strengths and limitations.
    Henderson AR.
    Clin Lab Med; 1997 Dec; 17(4):625-54. PubMed ID: 9439876
    [Abstract] [Full Text] [Related]

  • 2. Standardization activities of markers of cardiac damage: the need of a comprehensive approach.
    Panteghini M.
    Eur Heart J; 1998 Nov; 19 Suppl N():N8-11. PubMed ID: 9857932
    [Abstract] [Full Text] [Related]

  • 3. Cardiac markers in the assessment of acute coronary syndromes.
    Christenson RH, Newby LK, Ohman EM.
    Md Med J; 1997 Nov; Suppl():18-24. PubMed ID: 9470339
    [Abstract] [Full Text] [Related]

  • 4. [Troponins and other biochemical cardiac markers--time for a change].
    Strømme JH, Rolstad OJ, Mangschau A.
    Tidsskr Nor Laegeforen; 2000 Jun 20; 120(16):1863-9. PubMed ID: 10925614
    [Abstract] [Full Text] [Related]

  • 5. [Serum markers for ischemic myocardial damage].
    Fontes JP, Gonçalves M, Ribeiro VG.
    Rev Port Cardiol; 1999 Dec 20; 18(12):1129-36. PubMed ID: 10661020
    [Abstract] [Full Text] [Related]

  • 6. Troponin T or troponin I or CK-MB (or none?).
    Collinson PO.
    Eur Heart J; 1998 Nov 20; 19 Suppl N():N16-24. PubMed ID: 9857934
    [Abstract] [Full Text] [Related]

  • 7. Diagnostic strategies in myocardial infarction using myoglobin measurement.
    Plebani M, Zaninotto M.
    Eur Heart J; 1998 Nov 20; 19 Suppl N():N12-5. PubMed ID: 9857933
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of a proposed panel of cardiac markers for the diagnosis of acute myocardial infarction in patients with atraumatic chest pain.
    Chang CC, Ip MP, Hsu RM, Vrobel T.
    Arch Pathol Lab Med; 1998 Apr 20; 122(4):320-4. PubMed ID: 9648898
    [Abstract] [Full Text] [Related]

  • 9. Diagnostic efficacy of biochemical markers in diagnosis post-mortem of ischaemic heart disease.
    Pérez-Cárceles MD, Noguera J, Jiménez JL, Martínez P, Luna A, Osuna E.
    Forensic Sci Int; 2004 May 28; 142(1):1-7. PubMed ID: 15110067
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cardiac troponin is the most effective translational safety biomarker for myocardial injury in cardiotoxicity.
    O'Brien PJ.
    Toxicology; 2008 Mar 20; 245(3):206-18. PubMed ID: 18249481
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Biochemical markers of myocardial injury in children.
    Kaplan S.
    Circulation; 1997 Oct 21; 96(8):2496-7. PubMed ID: 9355882
    [No Abstract] [Full Text] [Related]

  • 15. Evaluation of heart fatty acid-binding protein as a rapid indicator for assessment of myocardial damage in pediatric cardiac surgery.
    Hasegawa T, Yoshimura N, Oka S, Ootaki Y, Toyoda Y, Yamaguchi M.
    J Thorac Cardiovasc Surg; 2004 Jun 21; 127(6):1697-702. PubMed ID: 15173726
    [Abstract] [Full Text] [Related]

  • 16. Very early diagnosis and risk stratification of patients admitted with suspected acute myocardial infarction by the combined evaluation of a single serum value of cardiac troponin-T, myoglobin, and creatine kinase MB(mass).
    Jurlander B, Clemmensen P, Wagner GS, Grande P.
    Eur Heart J; 2000 Mar 21; 21(5):382-9. PubMed ID: 10666352
    [Abstract] [Full Text] [Related]

  • 17. [Early exclusion of ischemic myocardial damage made possible by new biochemical cardiac markers].
    de Winter RJ, Koster RW, Sanders GT.
    Ned Tijdschr Geneeskd; 1998 Apr 25; 142(17):940-4. PubMed ID: 9623165
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Bedside multimarker testing for risk stratification in chest pain units: The chest pain evaluation by creatine kinase-MB, myoglobin, and troponin I (CHECKMATE) study.
    Apple FS, Jaffe AS.
    Circulation; 2001 Nov 27; 104(22):E125-6. PubMed ID: 11723038
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.